HEALTH CARE COSTS AMONG COPD PATIENTS ARE DOUBLED COMPARED TO A CONTROL POPULATION

Author(s)

Hoxha Ekström E1, Andersson M2, Gerhardsson de Verdier M3, Ekberg-Jansson A4, Hedner J5, Petzold M6, Torén K1, Svensson M7
1Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 2AstraZeneca Nordic-Baltic, Södertälje, Sweden, 3AstraZeneca, Gothenburg, Sweden, 4Angered local hospital, Gothenburg, Sweden, 5Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 6University of Gothenburg, Göteborg, Sweden, 7Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

OBJECTIVES:  To estimate the health care costs for COPD patients compared to a non-COPD population overall and by the frequency of COPD exacerbations. METHODS:  

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PRS25

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Work & Home Productivity - Indirect Costs

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×